108354-78-5 2-氨基-4,5,6,7-四氢苯并[b]噻吩-3-羧酸甲酯
词条详情加载中…
词条详情加载中…
安全说明
运输方式:冰袋运输。危险描述:非危险化学品(但具有皮肤刺激、严重眼刺激和呼吸道刺激危险)。危险等级:刺激性。防护措施:需遵循P261、P264等预防声明,如避免吸入、接触皮肤和眼睛,发生接触后及时采取相应急救措施。
用途与制备
化学合成。
医药
产率:82% 合成条件:With morpholine; sulfur In ethanol for 3 h; Reflux 实验步骤:化合物1,2a-1和3a-i的合成通过标准Gewald反应制备化合物1。将4.4g(0.05mol)吗啉滴加到环己酮(4.91g,0.05mol)、氰基乙酸甲酯(4.95g,0.05mol)和硫(1.92g,0.06mol)在35mL乙醇中的搅拌溶液中。完成后,将混合物再回流3小时。冷却至室温后,过滤分离沉淀物,用乙醇重结晶,得到浅黄色粉末(8.6g,产率82%),熔点128.2-129.4℃(文献值128-130℃),MS(GC-MS):m/z,211 [M + H]+,179,151,125,91,77,65,53。 参考文献:[1] Asian Journal of Chemistry, 2010, vol. 22, #9, p.7399-7404;[2] Organic and Biomolecular Chemistry, 2014, vol.12, #12, p.1942-1956;[3] Bioorganic and Medicinal Chemistry, 2016, vol.24, #8, p.1866-1871;[4] Tetrahedron, 2006, vol.62, #29, p.7121-7131;[5] Bioorganic and Medicinal Chemistry Letters, 2016, vol.26, #8, p.1947-1953;[6] Chemical Biology and Drug Design, 2010, vol.76, #2, p.116-129;[7] ChemMedChem, 2015, vol.10, #1, p.69-82;[8] Patent: US2010/81823, 2010, A1. Location in patent: Page/Page column 8;[9] Bioorganic and Medicinal Chemistry Letters, 2009, vol.19, #2, p.305-308;[10] Journal of Medicinal Chemistry, 2013, vol.56, #9, p.3620-3635;[11] Transition Metal Chemistry, 2014, vol.39, #4, p.431-442;[12] Synlett, 2014, vol.25, #9;[13] Journal of Molecular Liquids, 2017, vol.243, p.85-90;[14] Patent: WO2003/101979, 2003, A1. Location in patent: Page 19;[15] European Journal of Medicinal Chemistry, 2019, vol.161, p.239-251
产率:75% 合成条件:With sulfur; diethylamine In ethanol at 45-50℃; for 1 h; 实验步骤:中间体1.向硫(11.5g,359mmol)和2-氰基乙酸乙酯(38.7g,342mmol)在50mL乙醇中的悬浮液中逐滴加入环己烷-1-酮(33.6g,342mmol)。室温,然后加入二乙胺(DEA)(25.0g,342mmol),确保温度保持在50℃以下。将所得混合物在45℃下搅拌1小时,然后冷却至0℃并过滤。将收集的物质用冷乙醇洗涤并在真空下干燥,得到中间体1,为黄色固体(57.8g,收率:75%)。 参考文献:[1] Patent: WO2012/12712, 2012, A2. Location in patent: Page/Page column 47-48
产率:82% 合成条件:With morpholine; sulfur In ethanol for 3 h; Reflux 实验步骤:以环己酮和氰乙酸甲酯为原料,通过标准Gewald反应合成2-氨基-4,5,6,7-四氢苯并[b]噻吩-3-羧酸甲酯(化合物1)。向环己酮(4.91g,0.05mol)、氰乙酸甲酯(4.95g,0.05mol)和硫(1.92g,0.06mol)在35mL乙醇中的搅拌溶液中,缓慢滴加吗啉(4.4g,0.05mol)。滴加完毕后,将反应混合物回流3小时。反应完成后,冷却至室温,过滤收集沉淀物。通过乙醇重结晶纯化,得到浅黄色粉末状产物(8.6g,产率82%)。产物的熔点为128.2-129.4℃(文献值128-130℃),质谱(GC-MS)分析显示m/z为211 [M + H]+,碎片离子峰为179、151、125、91、77、65、53。 参考文献:[1] Asian Journal of Chemistry, 2010, vol.22, #9, p.7399-7404;[2] Organic and Biomolecular Chemistry, 2014, vol.12, #12, p.1942-1956;[3] Bioorganic and Medicinal Chemistry, 2016, vol.24, #8, p.1866-1871;[4] Tetrahedron, 2006, vol.62, #29, p.7121-7131;[5] Bioorganic and Medicinal Chemistry Letters, 2016, vol.26, #8, p.1947-1953;[6] Chemical Biology and Drug Design, 2010, vol.76, #2, p.116-129;[7] ChemMedChem, 2015, vol.10, #1, p.69-82;[8] Patent: US2010/81823, 2010, A1. Location in patent: Page/Page column 8;[9] Bioorganic and Medicinal Chemistry Letters, 2009, vol.19, #2, p.305-308;[10] Journal of Medicinal Chemistry, 2013, vol.56, #9, p.3620-3635;[11] Transition Metal Chemistry, 2014, vol.39, #4, p.431-442;[12] Synlett, 2014, vol.25, #9;[13] Journal of Molecular Liquids, 2017, vol.243, p.85-90;[14] Patent: WO2003/101979, 2003, A1. Location in patent: Page 19;[15] European Journal of Medicinal Chemistry, 2019, vol.161, p.239-251